Look for Drugs and Conditions

Prednisolone Acetate

Prednisolone Acetate

Prednisolone acetate is a corticosteroid medication belonging to the glucocorticoid class. It is derived from prednisolone and is commonly used in ophthalmic formulations. The acetate form allows for better ocular penetration, making it effective for treating various eye conditions.

Indications

-Ophthalmic Inflammation: Prednisolone acetate is commonly prescribed to reduce inflammation and swelling in the eyes. It is used to treat conditions such as uveitis, conjunctivitis, and keratitis. -Allergic Conditions: It may be indicated for managing allergic reactions affecting the eyes.


Dosage

Dosage may vary based on the specific eye condition being treated. A healthcare professional will determine the appropriate dosage. Typically, a small amount of the ophthalmic solution is instilled into the affected eye(s) at regular intervals.


Contra-Indications

Prednisolone acetate is contraindicated in individuals with a known hypersensitivity to corticosteroids. Systemic absorption may occur, so caution is advised in patients with systemic fungal infections.


Special Precautions

-Ocular Herpes Simplex: Use with caution in individuals with a history of ocular herpes simplex due to the potential for exacerbation. -Glaucoma: Prolonged use may elevate intraocular pressure; careful monitoring is necessary in patients with glaucoma. -Contact Lenses: Contact lenses should be removed prior to administration of the ophthalmic solution and can be reinserted after 15 minutes.


Side Effects

Common side effects may include temporary burning or stinging sensation upon application. Prolonged use or high doses may lead to increased intraocular pressure, cataract formation, and other ocular complications. Systemic absorption can cause adrenal suppression.


Drug Interactions

-CYP3A4 Inhibitors: Drugs that inhibit CYP3A4 may increase systemic exposure to prednisolone. -Aspirin and NSAIDs: Concurrent use with aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal bleeding.


Ad 5